Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;268(12):4415-4421.
doi: 10.1007/s00415-021-10721-4. Epub 2021 Jul 27.

Covid-19 and Parkinson's disease: an overview

S M Cartella  1 , C Terranova  2 , V Rizzo  2 , A Quartarone  2 , P Girlanda  2
Affiliations
Review

Covid-19 and Parkinson's disease: an overview

S M Cartella et al. J Neurol. 2021 Dec.

Abstract

In March 2020, WHO declared Covid-19 outbreak pandemic. There has been increasing evidence that frail, old, multi-pathological patients are at greater risk of developing severe Covid-19 infection than younger, healthy ones. Covid-19's impact on Parkinson's Disease (PD) patients could be analysed through both the influence on PD patients' health and their risk of developing severe Covid-19, and the consequences of lockdown and restrictive measures on mental and cognitive health on both patients and caregivers. Moreover, there are critical issues to be considered about patients' care and management through an unprecedented time like this. One important issue to consider is physiotherapy, as most patients cannot keep exercising because of restrictive measures which has profoundly impacted on their health. Lastly, the relationship between PD and Sars-Cov2 may be even more complicated than it seems as some studies have hypothesized a possible Covid-19-induced parkinsonism. Hereby, we review the state of the art about the relationship between Covid-19 and Parkinson's Disease, focusing on each of these five points.

Keywords: Covid-19; Movement disorders; Parkinson’s disease.

PubMed Disclaimer

Conflict of interest statement

The Authors have no disclosure to declare.

References

    1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793. doi: 10.1001/jama.2020.12839. - DOI - PubMed
    1. Meng L, et al. Intubation and ventilation amid the COVID-19 outbreak: Wuhan’s experience. Anesthesiology. 2020 doi: 10.1097/ALN.0000000000003296. - DOI - PMC - PubMed
    1. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507–13. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed
    1. Harenberg J, Favaloro E. COVID-19: Progression of disease and intravascular coagulation-present status and future perspectives. Clin Chem Lab Med. 2020;58(7):1029–1036. doi: 10.1515/cclm-2020-0502. - DOI - PubMed
    1. Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103–2109. doi: 10.1111/jth.14975. - DOI - PMC - PubMed